MedPath

Thromboelastometry and Ischemic Stroke (ThromboPredict)

Conditions
Cerebrovascular Stroke
Thrombolytic Therapy
Mechanical Thrombectomy
Registration Number
NCT04870684
Lead Sponsor
University Hospital, Caen
Brief Summary

In ischemic stroke, the recanalization rate after intravenous thrombolysis has been estimated to be less than 50% in patients with proximal intracranial artery occlusion; this rate is greater than 80% after endovascular thrombectomy. Thromboelastometry is a method of analysis of coagulation and fibrinolysis in whole blood. The main objective of this study is to evaluate whether the parameters obtained by thromboelastometry are predictive of revascularization at arteriography during mechanical thrombectomy, after treatment with rt-PA thrombolysis.

Detailed Description

This is a single-center prospective observational study at the University Hospital of Caen. Any patient presenting a neurological deficit of sudden onset, compatible with a ischemic stroke diagnosed on brain imaging and eligible for thrombolysis by rtPA and/or a endovascular thrombectomy procedure will be included. Clot formation kinetics will be assessed by thromboelastometry (ROTEM® and/or QUANTRA®) to determine the predictive parameters of revascularization. The parameters of clot formation and lysis as well as revascularization according to thrombo-inflammation processes will be studied.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Age > 18 years
  • Diagnosis of ischemic stroke
  • Decision of intravenous thrombolysis and/or endovascular thrombectomy by the neurologist and/or interventional neuroradiologist.
  • Patient admitted to the emergency department during the hours and days when the hematology-biology laboratory is open (Monday to Friday from 8:30 a.m. to 6:30 p.m.)
  • No opposition to the research from the patient or his relatives
  • Inclusions according to the emergency procedure
Exclusion Criteria
  • Age < 18 ans
  • Formal contraindication to thrombolysis and/or endovascular thrombectomy, disorders of hemostasis and anticoagulant treatment.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Does clot firmness could predict the success of the revascularizationOne hour after the blood test

clot firmness (MCF in millimeter, mm)

Prediction of the success of the revascularization procedure by thromboelastometryOne hour after the blood test

clot lysis time (seconde).

Secondary Outcome Measures
NameTimeMethod
Thomboelastometry and prediction of thrombolysis + thrombectomy efficacyduring thrombectomy procedure

effectiveness of thrombectomy will be assessed per-arteriogram by the TICI score (Grade 0: no perfusion Grade 1: penetration with minimal perfusion Grade 2: partial perfusion Grade 2A: only partial filling (less than two-thirds) of the entire vascular territory is visualized Grade 2B: complete filling of all of the expected vascular territory is visualized but the filling is slower than normal Grade 3: complete perfusion)

Thomboelastometry and prediction of thrombectomy efficacythrough study completion, an average of 3 years

puncture to recanalization (minute)

Prediction of success of thrombolysis"Day 1", "Day 3" after thrombolysis

presence or absence of a clot on MRI or angioscan

Thomboelastometry and prediction of neurological outcome"D0", "Day 1", "Day 3" after revascularization

The use of the NIHSS score will allow the neurological evaluation of the patient (at admission and 24h/72h after the recanalization attempt). Neurological outcome, as assessed by the NIHSS score, is considered favorable if the NIHSS score at 24h/72h post-recanalization is equal to 0 or 1 or if there is an improvement in the NIHSS score of at least four points between the admission score and the score at 24h/72h post-recanalization.

Thomboelastometry and prediction of success of recanalization by thrombectomy alonejust at the end of thrombectomy procedure

Effectiveness of thrombectomy will be assessed by the TICI score ((Grade 0: no perfusion Grade 1: penetration with minimal perfusion Grade 2: partial perfusion Grade 2A: only partial filling (less than two-thirds) of the entire vascular territory is visualized Grade 2B: complete filling of all of the expected vascular territory is visualized but the filling is slower than normal Grade 3: complete perfusion)

Trial Locations

Locations (1)

University hospital of Caen, emergency department

🇫🇷

Caen, France

University hospital of Caen, emergency department
🇫🇷Caen, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.